Your browser doesn't support javascript.
loading
The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.
Kim, Dong Hwan Dennis; Kong, Jee Hyun; Byeun, Ji Young; Jung, Chul Won; Xu, Wei; Liu, Xiangdong; Kamel-Reid, Suzanne; Kim, Yeo-Keyoung; Kim, Hyeoung-Joon; Lipton, Jeffrey H.
Afiliación
  • Kim DH; Chronic Myelogenous Leukemia Group, Department of Hematology/Medical Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. drkiim@medimail.co.kr
Clin Cancer Res ; 16(21): 5339-50, 2010 Nov 01.
Article en En | MEDLINE | ID: mdl-20959405

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Piperazinas / Pirimidinas / Leucemia Mielógena Crónica BCR-ABL Positiva / Interferón gamma Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2010 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Piperazinas / Pirimidinas / Leucemia Mielógena Crónica BCR-ABL Positiva / Interferón gamma Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2010 Tipo del documento: Article